Recent Advances of Computational Modeling for Predicting Drug Metabolism: A Perspective

被引:18
作者
Kar, Supratik [1 ]
Leszczynski, Jerzy [1 ]
机构
[1] Jackson State Univ, Dept Chem & Biochem, Interdisciplinary Ctr Nanotox, Jackson, MS USA
基金
美国国家科学基金会;
关键词
ADMET; ADR; docking; expert systems; In silico; metabolism; QSAR; SoM; IN-SILICO; CYTOCHROMES P450; RS-PREDICTOR; DISCOVERY; SITES; TOXICITY; ENZYMES; BINDING; SELECTIVITY; CYP3A4;
D O I
10.2174/1389200218666170607102104
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Absorption, Distribution, Metabolism, Excretion (ADME) properties along with drug induced adverse effects are the major reasons for the late stage failure of drug candidates as well as the cause for the expensive withdrawal of many approved drugs from the market. Considering the adverse effects of drugs, metabolism factor has great importance in medicinal chemistry and clinical pharmacology because it influences the deactivation, activation, detoxification and toxification of drugs. Methods: Computational methods are effective approaches to reduce the number of safety issues by analyzing possible links between chemical structures and metabolism followed by adverse effects, as they serve the integration of information on several levels to enhance the reliability of outcomes. Results and Discussion: In silico profiling of drug metabolism can help progress only those molecules along the discovery chain that is less likely to fail later in the drug discovery process. This positively impacts the very high costs of drug discovery and development. Understanding the science behind computational tools, their opportunities, and limitations is essential to make a true influence on drug discovery at different levels. If applied in a scientifically consequential way, computational tools may improve the capability to identify and evaluate potential drug molecules considering pharmacokinetic properties of drugs. Conclusion: Herein, current trends in computational modeling for predicting drug metabolism are reviewed highlighting new computational tools for drug metabolism prediction followed by reporting large and integrated databases of approved drugs associated with diverse metabolism issues.
引用
收藏
页码:1106 / 1122
页数:17
相关论文
共 89 条
  • [1] Adams S. E., 2010, THESIS
  • [2] Emerging Methods for Ensemble-Based Virtual Screening
    Amaro, Rommie E.
    Li, Wilfred W.
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (01) : 3 - 13
  • [3] Learning from 'big data': compounds and targets
    Bajorath, Juergen
    [J]. DRUG DISCOVERY TODAY, 2014, 19 (04) : 357 - 360
  • [4] Network medicine: a network-based approach to human disease
    Barabasi, Albert-Laszlo
    Gulbahce, Natali
    Loscalzo, Joseph
    [J]. NATURE REVIEWS GENETICS, 2011, 12 (01) : 56 - 68
  • [5] Bender A., 2014, DRUG METABOLISM PRED, P397
  • [6] Reaction site mapping of xenobiotic biotransformations
    Boyer, Scott
    Arnby, Catrin Hasselgren
    Carlsson, Lars
    Smith, James
    Stein, Viktor
    Glen, Robert C.
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2007, 47 (02) : 583 - 590
  • [7] Brown CM, 2008, DRUG METAB REV, V40, P1, DOI 10.1080/03602530802309742
  • [8] Chen S., 2014, DRUG METABOLISM PRED, P133, DOI DOI 10.1002/9783527673261.CH06
  • [9] Classification of Cytochrome P450 Inhibitors and Noninhibitors Using Combined Classifiers
    Cheng, Feixiong
    Yu, Yue
    Shen, Jie
    Yang, Lei
    Li, Weihua
    Liu, Guixia
    Lee, Philip W.
    Tang, Yun
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2011, 51 (05) : 996 - 1011
  • [10] MetaSite: Understanding metabolism in human cytochromes from the perspective of the chemist
    Cruciani, G
    Carosati, E
    De Boeck, B
    Ethirajulu, K
    Mackie, C
    Howe, T
    Vianello, R
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (22) : 6970 - 6979